Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Indian Minister Defends Price Controls In Face Of Industry Opposition

This article was originally published in PharmAsia News

Executive Summary

A minister of the Indian government defends the country's price-control policy as not as punitive on drug makers as they claim. Chemicals and Fertiliser Minister Ram Vilas Paswan denied claims of drug makers, saying they earn enough that they are not adversely affected by price controls. The industry has threatened to stop making certain drugs if controlled profit margins on bulk drugs, lowered in March, are not moved back up. Drug makers note the increased cost of raw materials they use to make their drugs and increased fuel and other costs. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068588

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel